Deprecated: Use of MediaWiki\Output\OutputPage::setIndexPolicy with index after noindex was deprecated in MediaWiki 1.43. [Called from MediaWiki\Output\OutputPage::setRobotPolicy in /home/forge/wikitrademarks.org/includes/Output/OutputPage.php at line 1008] in /home/forge/wikitrademarks.org/includes/debug/MWDebug.php on line 385
Category:May Khanna of Tucson AZ (US): Difference between revisions - WikiTrademarks Jump to content

Category:May Khanna of Tucson AZ (US): Difference between revisions

From WikiTrademarks
Updating Category:May_Khanna_of_Tucson_AZ_(US)
 
Updating Category:May_Khanna_of_Tucson_AZ_(US)
 
Line 2: Line 2:


=== Executive Summary ===
=== Executive Summary ===
May Khanna of Tucson AZ (US) is an inventor who has filed 2 patents. Their primary areas of innovation include No explanation available (1 patents), No explanation available (1 patents), No explanation available (1 patents), and they have worked with companies such as Arizona Board of Regents on Behalf of the University of Arizona (1 patents), ARIZONA BOARD OF REGENTS ON BEHALF OF THE UNIVERSITY OF ARIZONA (1 patents). Their most frequent collaborators include [[Category:Vijay Gokhale of Tucson AZ (US)|Vijay Gokhale of Tucson AZ (US)]] (1 collaborations), [[Category:Judith Tello Vega of Tucson AZ (US)|Judith Tello Vega of Tucson AZ (US)]] (1 collaborations), [[Category:Haley Williams of Tucson AZ (US)|Haley Williams of Tucson AZ (US)]] (1 collaborations).
May Khanna of Tucson AZ (US) is an inventor who has filed 2 patents. Their primary areas of innovation include PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES  (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms (1 patents), Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca (1 patents), Aptamers, i.e. nucleic acids binding a target molecule specifically and with high affinity without hybridising therewith {; Nucleic acids binding to non-nucleic acids, e.g. aptamers} (1 patents), and they have worked with companies such as Arizona Board of Regents on Behalf of the University of Arizona (1 patents), ARIZONA BOARD OF REGENTS ON BEHALF OF THE UNIVERSITY OF ARIZONA (1 patents). Their most frequent collaborators include [[Category:Vijay Gokhale of Tucson AZ (US)|Vijay Gokhale of Tucson AZ (US)]] (1 collaborations), [[Category:Judith Tello Vega of Tucson AZ (US)|Judith Tello Vega of Tucson AZ (US)]] (1 collaborations), [[Category:Haley Williams of Tucson AZ (US)|Haley Williams of Tucson AZ (US)]] (1 collaborations).


=== Patent Filing Activity ===
=== Patent Filing Activity ===
Line 11: Line 11:


==== List of Technology Areas ====
==== List of Technology Areas ====
* [[:Category:CPC_A61K31/4545|A61K31/4545]] (No explanation available): 1 patents
* [[:Category:CPC_A61K31/4545|A61K31/4545]] (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES  (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms): 1 patents
* [[:Category:CPC_A61K45/06|A61K45/06]] (No explanation available): 1 patents
* [[:Category:CPC_A61K45/06|A61K45/06]] (Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca): 1 patents
* [[:Category:CPC_C12N15/115|C12N15/115]] (No explanation available): 1 patents
* [[:Category:CPC_C12N15/115|C12N15/115]] (Aptamers, i.e. nucleic acids binding a target molecule specifically and with high affinity without hybridising therewith {; Nucleic acids binding to non-nucleic acids, e.g. aptamers}): 1 patents
* [[:Category:CPC_A61K47/64|A61K47/64]] (No explanation available): 1 patents
* [[:Category:CPC_A61K47/64|A61K47/64]] (Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent  (peptidic linkers): 1 patents
* [[:Category:CPC_C12N15/1048|C12N15/1048]] (No explanation available): 1 patents
* [[:Category:CPC_C12N15/1048|C12N15/1048]] ({SELEX}): 1 patents
* [[:Category:CPC_C12N2310/16|C12N2310/16]] (No explanation available): 1 patents
* [[:Category:CPC_C12N2310/16|C12N2310/16]] (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA  (microbiological testing media): 1 patents
* [[:Category:CPC_C12N2310/3513|C12N2310/3513]] (No explanation available): 1 patents
* [[:Category:CPC_C12N2310/3513|C12N2310/3513]] (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA  (microbiological testing media): 1 patents


=== Companies ===
=== Companies ===

Latest revision as of 09:05, 19 July 2024

May Khanna of Tucson AZ (US)

Executive Summary

May Khanna of Tucson AZ (US) is an inventor who has filed 2 patents. Their primary areas of innovation include PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms (1 patents), Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca (1 patents), Aptamers, i.e. nucleic acids binding a target molecule specifically and with high affinity without hybridising therewith {; Nucleic acids binding to non-nucleic acids, e.g. aptamers} (1 patents), and they have worked with companies such as Arizona Board of Regents on Behalf of the University of Arizona (1 patents), ARIZONA BOARD OF REGENTS ON BEHALF OF THE UNIVERSITY OF ARIZONA (1 patents). Their most frequent collaborators include (1 collaborations), (1 collaborations), (1 collaborations).

Patent Filing Activity

File:May Khanna of Tucson AZ (US) Monthly Patent Applications.png

Technology Areas

File:May Khanna of Tucson AZ (US) Top Technology Areas.png

List of Technology Areas

  • A61K31/4545 (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms): 1 patents
  • A61K45/06 (Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca): 1 patents
  • C12N15/115 (Aptamers, i.e. nucleic acids binding a target molecule specifically and with high affinity without hybridising therewith {; Nucleic acids binding to non-nucleic acids, e.g. aptamers}): 1 patents
  • A61K47/64 (Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent (peptidic linkers): 1 patents
  • C12N15/1048 ({SELEX}): 1 patents
  • C12N2310/16 (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media): 1 patents
  • C12N2310/3513 (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media): 1 patents

Companies

File:May Khanna of Tucson AZ (US) Top Companies.png

List of Companies

  • Arizona Board of Regents on Behalf of the University of Arizona: 1 patents
  • ARIZONA BOARD OF REGENTS ON BEHALF OF THE UNIVERSITY OF ARIZONA: 1 patents

Collaborators

Subcategories

This category has only the following subcategory.

Cookies help us deliver our services. By using our services, you agree to our use of cookies.